Trump: Drug pricing initiative in the US is being expanded
Washington, August 31 (Hibya) – Nine new pharmaceutical companies have reportedly joined US President Donald Trump’s drug pricing initiative.
US President Donald Trump’s drug pricing initiative, based on the most-favored-nation approach, is being expanded.
A statement from the US presidency said nine new pharmaceutical companies had committed to joining the initiative. The companies agreed to offer American patients the lowest drug prices they apply in their own countries.
With the new participants, the initiative aimed at lowering drug prices in the United States is expected to expand its scope.
Europe Asia News
Facebook
Tweeter
Whatsapp
